Tag: Asia Pacific

  • Fujifilm Philippines partners with Shinagawa to provide better healthcare to patients using modern tech

    Fujifilm Philippines partners with Shinagawa to provide better healthcare to patients using modern tech

    Fujifilm Philippines, a leading provider of digital imaging and healthcare solutions, will sign a memorandum of agreement today with Shinagawa Healthcare Solutions Corporation to bring advanced technology to patients.

    Masahiro Uehara, Fujifilm Philippines President, said that through this partnership, the two companies aim to combine their strengths to deliver innovative and high-quality healthcare solutions to patients.

    “We are thrilled to partner with Shinagawa Healthcare Solutions Corporation to provide better healthcare services to patients in the Philippines. Our advanced technology and expertise in the healthcare industry, combined with Shinagawa’s commitment to providing personalized care, will enable us to deliver innovative and high-quality healthcare solutions to patients in the Philippines,” he said.

    Shinagawa Healthcare Solutions Corporation, a subsidiary of the country’s top Lasik provider, Shinagawa Lasik & Aesthetics Center Corporation, is set to open a diagnostic and preventive care center in Bonifacio Global City, Taguig, next month. It will be the first Japanese standard health facility in the Philippines that focuses on preventive care.

    Through the collaboration, Uehara said Fujifilm will bring its innovative equipment to Shinagawa Diagnostic and Preventive Care Center to offer quick and comfortable procedures to patients.

    These include the Eluxeo Lite 6000, an endoscopy machine that features Multi-Light Technology to deliver high-quality imaging and superior visibility for enhanced patient comfort through flexible scope options.

    Another key instrument is the Supria 128 Slice CT Scan Machine, which offers painless and low-dose scanning capabilities. It also produces high-speed and top-notch quality images with lower power consumption.

    The Amulet Innovality is a mammogram machine designed with ergonomic armrests to ensure patient comfort and secure positioning, producing quick image intervals of just 15 seconds.

    Fujifilm’s FDR Smart X x-ray machine offers advanced functionality and compatibility with any X-ray system, delivering high image quality for precise and accurate results.

    Meanwhile, the Arietta Series is an ultrasound machine renowned for its broad diagnostic capabilities and top-notch imaging quality, producing reliable results that help with immediate critical surgical decisions.

    “Fujifilm Philippines’ commitment to quality and innovation aligns with their vision to provide exceptional healthcare services. We are thrilled to partner with them to bring their state-of-the-art imaging technology to our patients in the Philippines. Together, we can make a significant impact on the healthcare industry, revolutionizing the way healthcare is delivered and experienced,” he said.

    Prevention is key

    Masako Uemori, Shinagawa President, said the partnership will enable them to provide patients with the best possible care.

    “We believe that investing in preventive care is not only a wise decision but also a responsible one. By breaking the social stigma of reactive care and shifting our mindset towards proactive prevention, we can help Filipinos achieve better health outcomes and ultimately lead more fulfilling lives,” she said.

    Aside from Japanese standard health checkups, Shinagawa Diagnostic and Preventive Care Center will offer brain exams (MRI/MRA), full body exams (CT scan), digestive exams (ultrasound/endoscopy), health exams for women (mammography/ultrasound), laboratory, and allergy tests.

    Uemori said Shinagawa will partner with health maintenance organizations (HMOs) in the country to provide accessible, affordable, and comprehensive medical services to Filipinos.

    She also said they plan to promote health and wellness through events and seminars to raise public awareness about their overall well-being.

    “Our success in the field of eye care has enabled us to build a reputation as a leader in the industry. Our commitment to the latest technologies and Japanese standards for medical services has helped us to earn the trust of our patients, and we are proud to continue to deliver exceptional care that exceeds their expectations,” Uemori added.

    The future of healthcare

    Uemori said Shinagawa’s new Diagnostic & Preventive Care Center is committed to providing comprehensive and personalized healthcare plans that contribute to the early detection and prevention of disease.

    She said the company’s comprehensive medical examination process is designed to identify potential health issues before they become major problems, allowing for proactive intervention and treatment.

    Combined with Fujifilm’s cutting-edge and high-performance machines, Shinagawa’s state-of-the-art facility will enable doctors and health professionals to perform procedures quickly, comfortably, and stress-free for patients. Diagnosis and analysis will also have double reading by their partner Japanese doctors who have extensive experience in the field of preventive care.

    Shinagawa will also implement an efficient and streamlined operation using the Japanese Health Checkup Information System. With same-day results, patients can receive timely and accurate diagnoses and treatment plans without the added stress of waiting.

    Innovative imaging technology

    Fuji Photo Film Co., Ltd. (now FUJIFILM Holdings Corporation) was established in 1934 to produce high-quality photographic films. Within the first decade of its establishment, the company expanded its production to include motion pictures and X-ray films, in addition to its original focus on photographic films.

    In 2012, Fujifilm Philippines was founded as a sales subsidiary of Fujifilm’s regional headquarters in the Asia Pacific. The company primarily focuses on providing high-quality products and services to the Philippine market in areas such as electronics, photo imaging, industrial products, graphic design, and medical systems. To meet the increasing demand for its offerings and ensure consistent quality, the company opened its first branch in Cebu in 2019. This move also enabled Fujifilm Philippines to better serve customers in the Visayas and nearby Mindanao provinces by providing them with more localized support.

    During the height of the pandemic in 2020, Fujifilm Philippines supported local hospitals by installing the FDR Go PLUS, a digital mobile X-ray system that aided in diagnosing COVID-19 patients. The company also received FDA approval for the FDR nano and the FUJIFILM COVID-19 Ag Test Kit, which are expected to help healthcare workers diagnose and screen for COVID-19.

    The company is committed to supplying various products and services to support the medical frontline and promote human health.

    Reference:

    Lariza Garcia

  • Huawei 2021 Annual Report: Solid operations, investing in the future

    Huawei 2021 Annual Report: Solid operations, investing in the future

    Huawei released its 2021 Annual Report on March 28th, revealing that the company had maintained solid operations throughout the past year. As per the report, Huawei achieved CNY636.8 billion in revenue in 2021, and CNY113.7 billion in net profits, an increase of 75.9% year-on-year. The company’s R&D expenditure reached CNY142.7 billion in 2021, representing 22.4% of its total revenue, and bringing its total R&D expenditure over the past 10 years to over CNY845 billion. Moving forward, the company also plans to continuously increase investment in R&D.

    Huawei said, the performance was overall in line with forecast, its carrier business remained stable, enterprise business experienced steady growth, and consumer business quickly expanded into new domains. In addition, the company embarked on a fast track of ecosystem development.”

    Meng Wanzhou, Huawei’s CFO, spoke at the event, “Despite a revenue decline in 2021, our ability to make a profit and generate cash flows is increasing, and we are more capable of dealing with uncertainty.” Thanks to the enhanced profitability of its major businesses, the company’s cash flow from operating activities dramatically increased in 2021, amounting to CNY59.7 billion. Its liability ratio also dropped to 57.8%, and its overall financial structure has become more resilient and flexible.

    Meng Wanzhou, Huawei’s CFO, speaking at the press conference

    In 2021, Huawei’s carrier business generated CNY281.5 billion in revenue and helped carriers around the world deploy leading 5G networks. Third-party test results have found that 5G networks built by Huawei for customers in 13 countries, including Switzerland, Germany, Finland, the Netherlands, South Korea, and Saudi Arabia, provide the best user experience. By working with carriers and partners, Huawei has signed more than 3,000 commercial contracts for industrial 5G applications. These kinds of 5G applications are currently seeing large-scale commercial use in sectors like manufacturing, mines, iron & steel plants, ports, and hospitals.

    Thanks to continuing digital transformation trends, Huawei’s enterprise business also grew rapidly, generating CNY102.4 billion in revenue during 2021. In the past year, Huawei launched 11 scenario-based solutions for key sectors such as government, transportation, finance, energy, and manufacturing. The company also established multiple dedicated teams, including a Coal Mine Team, a Smart Road Team, and a Customs & Port Team, to combine resources in a way that more efficiently serves the needs of its customers.

    Over 700 cities and 267 Fortune Global 500 companies have chosen Huawei as their digital transformation partner and Huawei now works with more than 6,000 service and operation partners around the world. In the Philippines, benefited from a new system consisting of mobile devices and AI, forest rangers can receive real-time alerts of sound to identify rainforest destruction Via a mobile App, so they can take action quickly, according to Jun Zhang, the Director of Huawei Asia Pacific Public Relations Department.

    Huawei’s consumer business zeroed in on consumer wants and needs, further building out the global ecosystem for a smart, all-connected era, as part of the company’s Seamless AI Life strategy for consumers around the world. This business generated CNY243.4 billion in revenue in 2021 and continued to see steady sales growth in smart wearables, smart screens, true wireless stereo (TWS) earbuds, and Huawei Mobile Services (HMS). In particular, the smart wearable and smart screen segments both saw 30%+ year-on-year growth. In total, HarmonyOS was used in over 220 million Huawei devices as of 2021, becoming the world’s fastest growing mobile device operating system.

    During the past year, Huawei also focused on building out its openEuler, MindSpore, and HarmonyOS ecosystems based on the principles of open collaboration and shared growth. Over eight million developers are currently using Huawei’s open platforms, open-source software, and development tools to explore new business scenarios and business models.

    Simon Lin, the President of Huawei Asia Pacific stated, with stable workforce, financial and business fundamentals, the highest net profit in history, and our continued efforts to globalize under pressure and increase R&D investment, Huawei’s unwavering business strategy, focused on connectivity and computing and rapidly developing new businesses including digital power and cloud, is perfectly aligned to drive the digital economy in Asia Pacific.

    The company will advance its journey of digitalization, intelligent transformation, and low carbon. Relying on talent, scientific research, and an innovative spirit, Huawei said will continuously increase investment to reshape the paradigms for fundamental theories, architecture, and software, and build our long-term competitiveness.

    REFERENCE:

    ED UY